Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 25-May-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 9 of 9)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-May-13Ford Investor Services, Inc.N/AValue Graph: TALON THERAPEUT -- TLON1$11.50  View Abstract
24-May-13Ford Investor Services, Inc.N/AIndustry Value Graph: EXAS , GNBT , HEB , INSM , TLON -- DRUGS3$34.50  View Abstract
23-May-13Plunkett Research, Ltd.Jack W PlunkettTalon Therapeutics, Inc. (TLON) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages48$99  View Abstract
21-May-13GlobalDataGlobalDataTalon Therapeutics, Inc. (TLON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile43$250  View Abstract
17-May-13Reuters Investment ProfileN/ATalon Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
11-May-13S&P Capital IQ Quantitative ReportN/ATalon Therapeutics5$57.50  View Abstract
8-Apr-13GlobalDataGlobalDataTalon Therapeutics, Inc. (TLON) - Financial and Strategic SWOT Analysis Review35$125  View Abstract
5-Apr-13Pechala's ReportsFrantisek PechalaTALON THERAPEUTICS INC (TLON) 12-months forecast1$15  View Abstract
4-Apr-13Streetwise ReportsN/A6 Biotechs with Staggering Potential: Grant Zeng12$115  View Abstract

Independent Reports (Showing 1 to 9 of 9)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-May-13Ford Investor Services, Inc.N/AValue Graph: TALON THERAPEUT -- TLON1$11.50View Abstract
24-May-13Ford Investor Services, Inc.N/AIndustry Value Graph: EXAS , GNBT , HEB , INSM , TLON -- DRUGS3$34.50View Abstract
23-May-13Plunkett Research, Ltd.Jack W PlunkettTalon Therapeutics, Inc. (TLON) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages48$99View Abstract
21-May-13GlobalDataGlobalDataTalon Therapeutics, Inc. (TLON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile43$250View Abstract
17-May-13Reuters Investment ProfileN/ATalon Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
11-May-13S&P Capital IQ Quantitative ReportN/ATalon Therapeutics5$57.50View Abstract
8-Apr-13GlobalDataGlobalDataTalon Therapeutics, Inc. (TLON) - Financial and Strategic SWOT Analysis Review35$125View Abstract
5-Apr-13Pechala's ReportsFrantisek PechalaTALON THERAPEUTICS INC (TLON) 12-months forecast1$15View Abstract
4-Apr-13Streetwise ReportsN/A6 Biotechs with Staggering Potential: Grant Zeng12$115View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.